Muscular Development Forums - Powered by vBulletin

Results 1 to 5 of 5

Thread: Types of trials and control :.

  1. #1

    Default Types of trials and control :.

    Types of trials

    Open trial

    In an open trial, also called an open-label trial, the researcher knows the full details of the treatment, and so does the patient. These trials are open to challenge for bias, and they do nothing to reduce the placebo effect. However, sometimes they are unavoidable, as placebo treatments are not always possible.

    Usually this kind of study design is used in bioequivalence studies.

    Blind trials

    Single-blind trial

    In a single-blind trial, the researcher knows the details of the treatment but the patient does not. Because the patient does not know which treatment is being administered (the new treatment or another treatment) there might be no placebo effect. In practice, since the researcher knows, it is possible for him to treat the patient differently or to subconsciously hint to the patient important treatment-related details, thus influencing the outcome of the study.

    Double-blind trial

    In a double-blind trial, one researcher allocates a series of numbers to 'new treatment' or 'old treatment'. The second researcher is told the numbers, but not what they have been allocated to. Since the second researcher does not know, he cannot possibly tell the patient, directly or otherwise, and cannot give in to patient pressure to give him the new treatment. In this system, there is also often a more realistic distribution of sexes and ages of patients. Therefore double-blind trials are preferred, as they tend to give the most accurate results.

    Triple-blind trial

    Some randomized controlled trials are considered triple-blinded, although the meaning of this may vary according to the exact study design. The most common meaning is that the subject, researcher and person administering the treatment (often a pharmacist) are blinded to what is being given. Alternately, it may mean that the patient, researcher and statistician are blinded. The team monitoring the response may be unaware of the intervention being given in the control and study groups. These additional precautions are often in place with the more commonly accepted term "double blind trials", and thus the term "triple-blinded" is infrequently used. However, it connotes an additional layer of security to prevent undue influence of study results by anyone directly involved with the study.

    Aspects of control in clinical trials

    Traditionally the control in randomized controlled trials refers to studying a group of treated patients not in isolation but in comparison to other groups of patients, the control groups, who by not receiving the treatment under study give investigators important clues to the effectiveness of the treatment, its side effects, and the parameters that modify these effects.

    Other aspects of control include having other members of the research team, who will typically review the test to try to remove any factors which might skew the results. For example, it is important to have a test group which is reasonably balanced for ages and sexes of the subjects (unless this is a treatment which will never be used on a particular sex or age group). Additionally, peer review and/or review by government regulators can be seen as another source of control. These bodies examine the trial results when they are presented for publication or when the drug manufacturer applies for a license for the drug.

    The importance of having a control group cannot be overstated. Merely being told that one is receiving a miraculous cure can be enough to cure a patient—even if the pill contains nothing more than sugar. Additionally, the procedure itself can produce ill effects. For example, in one study[citation needed] on rabbits where these subjects were receiving daily injections of a drug, it was found that they were developing cancer. If this was a result of the treatment, it would obviously be unsuitable for testing in humans. Because this result was reflected equally between the control and test groups, the source of the problem was investigated and it was shown in this case that the administration of daily injections was the cancer risk—not the drug itself.

    The analysis of the trial results requires knowledge of medicine, epidemiology, and in particular statistics. The branch of statistics that deals specifically with biomedical research is biostatistics. Pharmaceutical firms employ groups of biostatisticians to try to make sense of the data. Likewise, regulators pay keen attention to the appropriateness of statistical methods used to analyze trial results.

    Types of control groups
    • Placebo concurrent control group
    • Dose-response concurrent control group
    • Active concurrent control group
    • No treatment concurrent control group
    • Historical control

    Wikipedia, Dec 22, 2008

  2. #2

    Default

    Great thread!
    This video should be required viewing on all forums. [please feel free to make it it's own sticky]


  3. #3
    Dr Pangloss
    Guest

    Default

    that's a fantastic video. It should go up in polotics and religion as well.

    thanks bro.

  4. #4

    Default

    very informative, thanks

  5. #5

    Default

    absolutely informative one and I'm going to take multiple advantages out of it .. this is a fact though that if you are well aware with pros and cons of the thing you are in you may utilize it in an efficient manner rather than just doing a waste of it...

Bookmarks

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •